2.46
price up icon21.18%   0.43
 
loading

Gt Biopharma Inc Stock (GTBP) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Selling, General, and Administrative
27.77%
2.314
1.811 1.758 1.526 2.015
Operating Income/Loss
2.43%
-3.091
-3.168 -3.122 -3.621 -3.665
Nonoperating Income/Loss
300.49%
0.825
0.206 0.706 1.629 3.438
Income/Loss From Continuing Operations Before Tax
23.50%
-2.266
-2.962 -2.416 -1.992 -0.227
Income/Loss From Continuing Operations After Tax
23.50%
-2.266
-2.962 -2.416 -1.992 -0.227
Net Income/Loss
23.50%
-2.266
-2.962 -2.416 -1.992 -0.227
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
103.56%
1.3806
-38.75 41.02 40.17 39.09
Diluted Average Shares
103.56%
1.3806
-38.75 41.02 40.17 -0.5405
Basic Earnings Per Share
70.29%
-1.64
-5.52 -0.06 -0.05 -0.01
Diluted Earnings Per Share
70.29%
-1.64
-5.52 -0.06 -0.05 -0.010
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):